Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Rinderon DP

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

59 API Suppliers, 16 USDMF, 8 CEP/COS, 6 JDMF, 9 EU WC, 2 KDMF, 12 NDC API, 38 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

35 Drugs in Development

35 Drugs in Development

FINISHED DOSAGE FORMULATIONS

303 FDF Dossiers, 79 FDA Orange Book, 158 Europe, 3 Canada, 32 Australia, 9 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE, CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - EQ 0.05% BASE, OINTMENT;TOPICAL - EQ 0.05% BASE, CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 3 DKSH, 1 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 1 Actylis, 11 BASF, 1 Clariant, 4 Corel Pharma Chem, 2 Finar, 4 Lubrizol Life Science Health, 11 Roquette, 1 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

26 Topical, 13 Film Formers & Plasticizers, 9 Parenteral, 8 Emulsifying Agents, 7 Solubilizers, 7 Thickeners and Stabilizers, 5 Lubricants & Glidants, 5 Fillers, Diluents & Binders, 4 Coating Systems & Additives, 4 Taste Masking, 3 Direct Compression, 3 Surfactant & Foaming Agents, 2 Granulation, 2 Controlled & Modified Release, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin, 1 Rheology Modifiers, 1 Co-Processed Excipients

DIGITAL CONTENT

48 News #PharmaBuzz

48 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions, 17 Regulatory FDF Prices, 16 Annual Reports

MARKET PLACE

23 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 5 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	Avik Pharmaceutical Limited	India	Hiple Co., Ltd.	20210427-211-J-955	betamethasone dipropionate	2021-04-27	Avik Pharmaceutical Limited	India	A-1/7 & A-1/8, 1ST Phase, GIDC, City : Vapi - 396 195, Dist. Valsad, Gujarat State, India
29/11/2025	Symbiotica	Malaysia	Ace Biopharm Co., Ltd.	20211221-211-J-1097	betamethasone dipropionate	2021-12-21	Symbiotica Specialty Ingredients Sdn. Bhd.	Malaysia	No. 518, Jalan Waja 4, Taman Industri Waja, 09000 Kulim, Kedah, Malaysia

Rinderon DP

Rinderon DP

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

59 API Suppliers

16 USDMF

8 CEP/COS

6 JDMF

9 EU WC

2 KDMF

12 NDC API

38 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

35 Drugs in Development

FINISHED DOSAGE FORMULATIONS

303 FDF Dossiers

79 FDA Orange Book

158 Europe

3 Canada

32 Australia

9 South Africa

22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE

CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - EQ 0.05% BASE

OINTMENT;TOPICAL - EQ 0.05% BASE

CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;TOPICAL - 0.064%;0.005%

SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

2 SPI Pharma

3 DKSH

1 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

3 Kirsch Pharma

1 Actylis

11 BASF

1 Clariant

4 Corel Pharma Chem

2 Finar

4 Lubrizol Life Science Health

11 Roquette

1 Seppic

2 Shandong Focus Biotechnology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

26 Topical

13 Film Formers & Plasticizers

9 Parenteral

8 Emulsifying Agents

7 Solubilizers

7 Thickeners and Stabilizers

5 Lubricants & Glidants

5 Fillers, Diluents & Binders

4 Coating Systems & Additives

4 Taste Masking

3 Direct Compression

3 Surfactant & Foaming Agents

2 Granulation

2 Controlled & Modified Release

2 Chewable & Orodispersible Aids

1 Soft Gelatin

1 Rheology Modifiers

1 Co-Processed Excipients

DIGITAL CONTENT

48 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions

17 Regulatory FDF Prices

16 Annual Reports

MARKET PLACE

CREAM;TOPICAL - EQ 0.05% BASE;1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons